$IMPL Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in IMPEL NEUROPHARMA INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in IMPEL NEUROPHARMA INC. Get notifications about new insider transactions in IMPEL NEUROPHARMA INC for free.

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.00713,06400
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.005,162,96900
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.00995,71400
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.007,206,21600
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.001,073,30800
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.007,772,63400
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.001,605,71100
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.0011,628,17400
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyP15.0069,3801,040,700349,674280.3 K to 349.7 K (+24.75 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyP15.00505,6207,584,3002,535,1152 M to 2.5 M (+24.91 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC13.5012,311166,199280,294268 K to 280.3 K (+4.59 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC13.5089,1451,203,4582,029,4951.9 M to 2 M (+4.59 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.0043,5500267,983224.4 K to 268 K (+19.40 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.00315,32801,940,3501.6 M to 1.9 M (+19.40 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.0060,8130224,433163.6 K to 224.4 K (+37.17 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.00440,11901,625,0221.2 M to 1.6 M (+37.14 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.0065,5520163,62098.1 K to 163.6 K (+66.84 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.00474,71301,184,903710.2 K to 1.2 M (+66.84 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.0098,068098,0680 to 98.1 K
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Vivo Capital VIII, LLC10% OwnerBuyC0.00710,1900710,1900 to 710.2 K
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerOption ExerciseC13.501,359,79918,357,2870
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerOption ExerciseC0.005,876,03400
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerOption ExerciseC0.008,201,93000
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerOption ExerciseC0.008,845,94200
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerOption ExerciseC0.0013,233,88500
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerBuyP15.00575,0008,625,000575,0000 to 575 K
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerBuyC13.50101,4571,369,6702,309,7912.2 M to 2.3 M (+4.59 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerBuyC0.00358,87802,208,3341.8 M to 2.2 M (+19.40 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerBuyC0.00500,93201,849,4561.3 M to 1.8 M (+37.15 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerBuyC0.00540,26501,348,524808.3 K to 1.3 M (+66.84 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerBuyC0.00808,2590808,2590 to 808.3 K
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Norwest Venture Partners XIV, ...10% OwnerOption ExerciseC0.0035,256,20600
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Norwest Venture Partners XIV, ...10% OwnerBuyP15.00825,00012,375,0003,077,1982.3 M to 3.1 M (+36.63 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Norwest Venture Partners XIV, ...10% OwnerBuyC0.002,153,27102,252,19898.9 K to 2.3 M (+2,176.63 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Norwest Venture Partners XIV, ...10% OwnerBuyC13.5098,9271,335,51598,9270 to 98.9 K
Apr 29 2021IMPLIMPEL NEUROPHARMA ...venBio Global Strategic Fund I ...Option ExerciseC0.0013,233,88500
Apr 29 2021IMPLIMPEL NEUROPHARMA ...venBio Global Strategic Fund I ...Option ExerciseC0.008,845,94200
Apr 29 2021IMPLIMPEL NEUROPHARMA ...venBio Global Strategic Fund I ...Option ExerciseC0.008,201,93000
Apr 29 2021IMPLIMPEL NEUROPHARMA ...venBio Global Strategic Fund I ...Option ExerciseC0.005,876,03400
Apr 29 2021IMPLIMPEL NEUROPHARMA ...venBio Global Strategic Fund I ...BuyP15.00450,0006,750,0002,759,7912.3 M to 2.8 M (+19.48 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...venBio Global Strategic Fund I ...BuyC0.002,309,79102,309,7910 to 2.3 M
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorOption ExerciseC0.00143,98600
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorOption ExerciseX0.0047,2360143,986
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorOption ExerciseX0.0047,26300
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorOption ExerciseC0.00120,44700
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorOption ExerciseX0.0013,7560120,447
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorOption ExerciseX0.0013,75600
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorOption ExerciseC0.0061,10900
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorBuyC13.502713,65918,02717.8 K to 18 K (+1.53 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorSellJ0.001,666017,75619.4 K to 17.8 K (-8.58 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorBuyC0.008,793019,42210.6 K to 19.4 K (+82.73 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorSellJ0.00458010,62911.1 K to 10.6 K (-4.13 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorBuyC0.007,355011,0873.7 K to 11.1 K (+197.08 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...PARKER H STEWARTDirectorBuyC0.003,73203,7320 to 3.7 K
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Hoekman JohnChief Scientific Of ...Option ExerciseC0.0069,65700
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Hoekman JohnChief Scientific Of ...Option ExerciseX0.008,523069,657
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Hoekman JohnChief Scientific Of ...Option ExerciseX0.008,52300
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Hoekman JohnChief Scientific Of ...SellJ0.002750108,221108.5 K to 108.2 K (-0.25 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...Hoekman JohnChief Scientific Of ...BuyC0.004,5230108,496104 K to 108.5 K (+4.35 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...KKR Iris Investors LLCOption ExerciseC0.0042,307,44800
Apr 29 2021IMPLIMPEL NEUROPHARMA ...KKR Iris Investors LLCBuyP15.001,100,00016,500,0003,802,6382.7 M to 3.8 M (+40.70 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...KKR Iris Investors LLCBuyJ13.50118,7121,602,6122,702,6382.6 M to 2.7 M (+4.59 %)
Apr 29 2021IMPLIMPEL NEUROPHARMA ...KKR Iris Investors LLCBuyC0.002,583,92602,583,9260 to 2.6 M
Apr 26 2021IMPLIMPEL NEUROPHARMA ...5AM Ventures V, L.P.10% OwnerOption ExerciseJ0.001,359,79901,359,799

Page:   1

Contact us | Follow us on Twitter